AnnJi Pharmaceutical, AJ201, Rosolutamide, SBMA, Spinal and Bulbar Muscular Atrophy, Kennedy’s Disease, Phase 3 Clinical Trial

Taipei, Taiwan, October 5, 2026 AnnJi Pharmaceutical Co., Ltd. has announced that it is advancing AJ201 (rosolutamide) into the...